Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Scarrott

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|August 26, 2017
Gene Therapy in the Nervous System: Failures and SuccessesJayanth S Chandran, Joseph M Scarrott, Pamela J Shaw, et al.
Expert Opinion on Biological Therapy|May 12, 2015
Current developments in gene therapy for amyotrophic lateral sclerosisJoseph M Scarrott, Saúl Herranz-Martín, Aziza R Alrafiah, et al.
Biotechnology Journal|December 10, 2022
Increased recombinant adeno-associated virus production by HEK293 cells using small molecule chemical additivesJoseph M Scarrott, Yusuf B Johari, Thilo H Pohle, et al.
Biotechnology Journal|June 20, 2024
Molecular design of controllable recombinant adeno-associated virus (AAV) expression systems for enhanced vector productionYusuf B Johari, Thilo H Pohle, Jared Whitehead, et al.
Biotechnology Journal|April 28, 2022
Engineering of the CMV promoter for controlled expression of recombinant genes in HEK293 cellsYusuf B Johari, Joseph M Scarrott, Thilo H Pohle, et al.
Brain Communications|January 12, 2023
Ap4b1-knockout mouse model of hereditary spastic paraplegia type 47 displays motor dysfunction, aberrant brain morphology and ATG9A mislocalizationJoseph M Scarrott, João Alves-Cruzeiro, Paolo M Marchi, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALSTommaso Iannitti, Joseph M Scarrott, Shibi Likhite, et al.
Biotechnology and Bioengineering|October 31, 2020
Production of trimeric SARS-CoV-2 spike protein by CHO cells for serological COVID-19 testingYusuf B Johari, Stephen R P Jaffé, Joseph M Scarrott, et al.
EMBO Molecular Medicine|October 2, 2024
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47Jessica P Wiseman, Joseph M Scarrott, João Alves-Cruzeiro, et al.
Human Molecular Genetics|January 10, 2020
Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein traffickingRobert Behne, Julian Teinert, Miriam Wimmer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|August 26, 2017
Gene Therapy in the Nervous System: Failures and SuccessesJayanth S Chandran, Joseph M Scarrott, Pamela J Shaw, et al.
Expert Opinion on Biological Therapy|May 12, 2015
Current developments in gene therapy for amyotrophic lateral sclerosisJoseph M Scarrott, Saúl Herranz-Martín, Aziza R Alrafiah, et al.
Biotechnology Journal|December 10, 2022
Increased recombinant adeno-associated virus production by HEK293 cells using small molecule chemical additivesJoseph M Scarrott, Yusuf B Johari, Thilo H Pohle, et al.
Biotechnology Journal|June 20, 2024
Molecular design of controllable recombinant adeno-associated virus (AAV) expression systems for enhanced vector productionYusuf B Johari, Thilo H Pohle, Jared Whitehead, et al.
Biotechnology Journal|April 28, 2022
Engineering of the CMV promoter for controlled expression of recombinant genes in HEK293 cellsYusuf B Johari, Joseph M Scarrott, Thilo H Pohle, et al.
Brain Communications|January 12, 2023
Ap4b1-knockout mouse model of hereditary spastic paraplegia type 47 displays motor dysfunction, aberrant brain morphology and ATG9A mislocalizationJoseph M Scarrott, João Alves-Cruzeiro, Paolo M Marchi, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALSTommaso Iannitti, Joseph M Scarrott, Shibi Likhite, et al.
Biotechnology and Bioengineering|October 31, 2020
Production of trimeric SARS-CoV-2 spike protein by CHO cells for serological COVID-19 testingYusuf B Johari, Stephen R P Jaffé, Joseph M Scarrott, et al.
EMBO Molecular Medicine|October 2, 2024
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47Jessica P Wiseman, Joseph M Scarrott, João Alves-Cruzeiro, et al.
Human Molecular Genetics|January 10, 2020
Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein traffickingRobert Behne, Julian Teinert, Miriam Wimmer, et al.
Pageof 1